Alan Bidgoli
Research
Publications
-
Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy Outcomes.
Transplant Cell Ther Volume: 31 Page(s): 123 - 134
03/01/2025 Authors: Dandoy CE; Auletta JJ; Badia P; Bidgoli A; Daraiseh NM; DeSalvo AM; Diaz J; Davies SM; Demmel K; Cook E -
Successful hematopoietic cell transplantation utilizing myeloablative reduced-toxicity conditioning in Chediak-Higashi syndrome.
J Allergy Clin Immunol Volume: 155 Page(s): 659 - 661
02/01/2025 Authors: Bidgoli A; Kunvarjee B; Scaradavou A; O'Reilly RJ; Boelens JJ; Prockop SE; Oved JH -
The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committee.
Cytotherapy Volume: 27 Page(s): 78 - 84
01/01/2025 Authors: Oved JH; Russell A; DeZern A; Prockop SE; Bonfim C; Sharma A; Purtill D; Lakkaraja M; Bidgoli A; Bhoopalan SV -
International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges faced.
Cytotherapy Volume: 26 Page(s): 1411 - 1420
11/01/2024 Authors: Gupta AO; Azul M; Bhoopalan SV; Abraham A; Bertaina A; Bidgoli A; Bonfim C; DeZern A; Li J; Louis CU -
Real-World Application of Recently Proposed ASTCT/CIBMTR/EBMT/APBMT Consensus Risk Stratification for Transplantation-Associated Thrombotic Microangiopathy in Children.
Transplant Cell Ther Volume: 30 Page(s): 929.e1 - 929.e6
09/01/2024 Authors: Schoettler ML; Ofori J; Bryson E; Spencer K; Qayed M; Stenger E; Bidgoli A; Chonat S; Westbrook A; Williams KM -
Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee.
Cytotherapy Volume: 26 Page(s): 660 - 671
07/01/2024 Authors: John TD; Maron G; Abraham A; Bertaina A; Bhoopalan SV; Bidgoli A; Bonfim C; Coleman Z; DeZern A; Li J -
Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyond.
Cytotherapy Volume: 26 Page(s): 546 - 555
06/01/2024 Authors: Belbachir S; Abraham A; Sharma A; Prockop S; DeZern AE; Bonfim C; Bidgoli A; Li J; Ruggeri A; Bertaina A -
Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations.
J Allergy Clin Immunol Volume: 152 Page(s): 815 - 817
09/01/2023 Authors: Kunvarjee B; Bidgoli A; Madan RP; Vidal E; McAvoy D; Hosszu KK; Scaradavou A; Spitzer BG; Curran KJ; Cancio M -
Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantation.
JCI Insight Volume: 8
05/22/2023 Authors: Han Y; Bidgoli A; DePriest BP; Mndez A; Bijangi-Vishehsaraei K; Perez-Albuerne ED; Krance RA; Renbarger J; Skiles JL; Choi SW -
Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease.
Transplant Cell Ther Volume: 28 Page(s): 657 - 666
10/01/2022 Authors: Bidgoli A; DePriest BP; Saatloo MV; Jiang H; Fu D; Paczesny S